10 ms·
I’ll start by stating the companies who are taking these egregious price increases are only shooting themselves in the foot. They’ll end up in front of a Senat
by refurb 7y ago
I’ll start by stating the companies who are taking these egregious price increases are only shooting themselves in the foot. They’ll end up in front of a Senate committee before long.
That said, profit attracts investment. The rare diseases are a great example. Who wants to spend $50M creating a drug for a disease with so few people you’d only lose money?
Genzyme started the trend of charging a lot, with the caveat than any insurer might have a handful of patients. The cost per member might be $0.10.
Insurers said ok and investment flood the rare disease space. We’re talking hundreds of billions. Now some people with a rare disease have treatment.